Kristina Lövgren

6.3k total citations · 1 hit paper
32 papers, 2.5k citations indexed

About

Kristina Lövgren is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Kristina Lövgren has authored 32 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Surgery and 11 papers in Cancer Research. Recurrent topics in Kristina Lövgren's work include Bladder and Urothelial Cancer Treatments (13 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (9 papers). Kristina Lövgren is often cited by papers focused on Bladder and Urothelial Cancer Treatments (13 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (9 papers). Kristina Lövgren collaborates with scholars based in Sweden, United States and Finland. Kristina Lövgren's co-authors include Mårten Fernö, Markus Ringnér, Fredrik Liedberg, Mattias Höglund, Pär‐Ola Bendahl, Gottfrid Sjödahl, Gunilla Chebil, Dorthe Grabau, Oliver Patschan and Sigurður Guðjónsson and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kristina Lövgren

32 papers receiving 2.5k citations

Hit Papers

A Molecular Taxonomy for Urothelial Carcinoma 2012 2026 2016 2021 2012 200 400 600

Peers

Kristina Lövgren
Tobias Zellweger Switzerland
David J. DeGraff United States
Woonyoung Choi United States
Shi‐Ming Tu United States
Michael Goggins United States
G Sauter United States
Kristina Lövgren
Citations per year, relative to Kristina Lövgren Kristina Lövgren (= 1×) peers Gunilla Chebil

Countries citing papers authored by Kristina Lövgren

Since Specialization
Citations

This map shows the geographic impact of Kristina Lövgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Lövgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Lövgren more than expected).

Fields of papers citing papers by Kristina Lövgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Lövgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Lövgren. The network helps show where Kristina Lövgren may publish in the future.

Co-authorship network of co-authors of Kristina Lövgren

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Lövgren. A scholar is included among the top collaborators of Kristina Lövgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Lövgren. Kristina Lövgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sjödahl, Gottfrid, Carina Bernardo, Gunilla Chebil, et al.. (2021). Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. European Urology. 81(5). 523–532. 89 indexed citations
2.
Sjödahl, Gottfrid, Pontus Eriksson, Kristina Lövgren, et al.. (2018). Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases. Modern Pathology. 31(12). 1869–1881. 40 indexed citations
3.
Alkner, Sara, Pär‐Ola Bendahl, Anna Ehinger, et al.. (2016). Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer. PLoS ONE. 11(3). e0150977–e0150977. 8 indexed citations
4.
Patschan, Oliver, Gottfrid Sjödahl, Gunilla Chebil, et al.. (2015). A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma. European Urology. 68(5). 824–832. 92 indexed citations
5.
Sjödahl, Gottfrid, Kristina Lövgren, Martin Lauss, et al.. (2014). Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors. Urologic Oncology Seminars and Original Investigations. 32(6). 791–797. 99 indexed citations
6.
Broselid, Stefan, Benxu Cheng, Martin Sjöström, et al.. (2013). G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients. Clinical Cancer Research. 19(7). 1681–1692. 35 indexed citations
7.
8.
Sjödahl, Gottfrid, Kristina Lövgren, Martin Lauss, et al.. (2013). Toward a Molecular Pathologic Classification of Urothelial Carcinoma. American Journal Of Pathology. 183(3). 681–691. 130 indexed citations
9.
Sjödahl, Gottfrid, Martin Lauss, Kristina Lövgren, et al.. (2012). A Molecular Taxonomy for Urothelial Carcinoma. Clinical Cancer Research. 18(12). 3377–3386. 637 indexed citations breakdown →
10.
Lindgren, David, Gottfrid Sjödahl, Martin Lauss, et al.. (2012). Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma. PLoS ONE. 7(6). e38863–e38863. 159 indexed citations
11.
Holm, Karolina, Dorthe Grabau, Kristina Lövgren, et al.. (2012). Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Molecular Oncology. 6(5). 494–506. 123 indexed citations
12.
Lauss, Martin, Mattias Aine, Gottfrid Sjödahl, et al.. (2012). DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status. Epigenetics. 7(8). 858–867. 39 indexed citations
13.
Olsson, Eleonor, Gabriella Honeth, Pär‐Ola Bendahl, et al.. (2011). CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer. 11(1). 418–418. 173 indexed citations
14.
Sjöström, Martin, Stefan Broselid, Karin Jirström, et al.. (2011). P4-09-02: G Protein-Coupled Estrogen Receptor 1 Positively Correlates with Estrogen Receptor a Expression and Increased Distant Disease-Free Survival of Breast Cancer Patients.. Cancer Research. 71(24_Supplement). P4–9. 1 indexed citations
15.
Kovács, Anikó, Kristina Lövgren, Szilárd Nemes, et al.. (2010). Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray. BMC Cancer. 10(1). 296–296. 30 indexed citations
16.
Klintman, Marie, Pär‐Ola Bendahl, Dorthe Grabau, et al.. (2009). The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer. Modern Pathology. 23(2). 251–259. 73 indexed citations
17.
Alkner, Sara, Pär‐Ola Bendahl, Dorthe Grabau, et al.. (2009). AIB1 is a predictive factor for tamoxifen response in premenopausal women. Annals of Oncology. 21(2). 238–244. 31 indexed citations
18.
Honeth, Gabriella, Pär‐Ola Bendahl, Markus Ringnér, et al.. (2008). The CD44+/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Research. 10(3). R53–R53. 452 indexed citations
19.
Liedberg, Fredrik, Harald Anderson, Gunilla Chebil, et al.. (2007). Tissue microarray based analysis of prognostic markers in invasive bladder cancer: Much effort to no avail?. Urologic Oncology Seminars and Original Investigations. 26(1). 17–24. 28 indexed citations
20.
Bendahl, Pär‐Ola, Dorthe Grabau, Jorma Isola, et al.. (2007). Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer. Breast Cancer Research and Treatment. 109(2). 255–262. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026